Co-Authors
This is a "connection" page, showing publications co-authored by Gunnar Gislason and Thomas Gerds.
Connection Strength
1.920
-
Cardiovascular comorbidities as predictors for severe COVID-19 infection or death. Eur Heart J Qual Care Clin Outcomes. 2021 03 15; 7(2):172-180.
Score: 0.234
-
Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study. Thromb Res. 2021 03; 199:97-100.
Score: 0.231
-
The association between cardiovascular disease admission rates and the coronavirus disease 2019 lockdown and reopening of a nation: a Danish nationwide cohort study. Eur Heart J Qual Care Clin Outcomes. 2022 01 05; 8(1):14-22.
Score: 0.062
-
Association Between Male Sex and Outcomes of Coronavirus Disease 2019 (COVID-19)-A Danish Nationwide, Register-based Study. Clin Infect Dis. 2021 12 06; 73(11):e4025-e4030.
Score: 0.061
-
All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study. Eur Heart J. 2021 Apr 14; 42(15):1516-1523.
Score: 0.059
-
Risk of major cardiovascular events according to educational level before and after the initial COVID-19 public lockdown: a nationwide study. J Epidemiol Community Health. 2021 09; 75(9):829-835.
Score: 0.058
-
Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study. BMJ Open. 2020 12 04; 10(12):e044421.
Score: 0.057
-
Association Between Prescribed Ibuprofen and Severe COVID-19 Infection: A Nationwide Register-Based Cohort Study. Clin Transl Sci. 2020 11; 13(6):1103-1107.
Score: 0.057
-
Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction. Circulation. 2020 11 24; 142(21):2080-2082.
Score: 0.057
-
Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic. Int J Cardiol Heart Vasc. 2020 Dec; 31:100659.
Score: 0.057
-
Effect of COVID-19 on First-Time Acute Stroke and Transient Ischemic Attack Admission Rates and Prognosis in Denmark: A Nationwide Cohort Study. Circulation. 2020 09 22; 142(12):1227-1229.
Score: 0.056
-
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality. JAMA. 2020 Jul 14; 324(2):168-177.
Score: 0.056
-
Charlson Comorbidity Index Score and Risk of Severe Outcome and Death in Danish COVID-19 Patients. J Gen Intern Med. 2020 09; 35(9):2801-2803.
Score: 0.056
-
Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark: A Nationwide Cohort Study. Circ Heart Fail. 2020 06; 13(6):e007274.
Score: 0.055
-
New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people. Eur Heart J. 2020 06 01; 41(32):3072-3079.
Score: 0.055
-
Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study. Eur Heart J. 2019 12 07; 40(46):3782-3790.
Score: 0.053
-
Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction. Eur Heart J. 2019 06 21; 40(24):1963-1970.
Score: 0.052
-
Bystander cardiopulmonary resuscitation and long-term outcomes in out-of-hospital cardiac arrest according to location of arrest. Eur Heart J. 2019 01 14; 40(3):309-318.
Score: 0.050
-
Risk of post-discharge fall-related injuries among adult patients with syncope: A nationwide cohort study. PLoS One. 2018; 13(11):e0206936.
Score: 0.050
-
Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study. Eur Heart J Cardiovasc Pharmacother. 2018 10 01; 4(4):220-227.
Score: 0.049
-
Risk of Myocardial Infarction in Anticoagulated Patients With Atrial Fibrillation. J Am Coll Cardiol. 2018 07 03; 72(1):17-26.
Score: 0.048
-
Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study. Eur Heart J. 2018 05 14; 39(19):1698-1705a.
Score: 0.048
-
Survival after out-of-hospital cardiac arrest in nursing homes - A nationwide study. Resuscitation. 2018 04; 125:90-98.
Score: 0.047
-
Out-of-hospital cardiac arrest: Probability of bystander defibrillation relative to distance to nearest automated external defibrillator. Resuscitation. 2018 03; 124:138-144.
Score: 0.047
-
Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation. Heart. 2018 06; 104(11):912-920.
Score: 0.046
-
Bystander Efforts and 1-Year Outcomes in Out-of-Hospital Cardiac Arrest. N Engl J Med. 2017 05 04; 376(18):1737-1747.
Score: 0.045
-
Bystander Defibrillation for Out-of-Hospital Cardiac Arrest in Public vs Residential Locations. JAMA Cardiol. 2017 05 01; 2(5):507-514.
Score: 0.045
-
Comparative safety and effectiveness of rivaroxaban versus VKAs in patients with venous thromboembolism. A Danish nationwide registry-based study. Thromb Haemost. 2017 06 02; 117(6):1182-1191.
Score: 0.044
-
Incidence and survival outcome according to heart rhythm during resuscitation attempt in out-of-hospital cardiac arrest patients with presumed cardiac etiology. Resuscitation. 2017 05; 114:157-163.
Score: 0.044
-
Return to the Workforce After First Hospitalization for Heart Failure: A Danish Nationwide Cohort Study. Circulation. 2016 Oct 04; 134(14):999-1009.
Score: 0.042